Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your experience. Save up to 40% More details

Breaking News

Dow Futures Rise 300 Pts; Bouncing Ahead of ADP, ISM Data

3 Biotech Stocks To Watch In December

By (Sean Sechler )Stock MarketsDec 02, 2020 06:10AM ET
3 Biotech Stocks To Watch In December
By (Sean Sechler )   |  Dec 02, 2020 06:10AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items

Although investing in biotech stocks can be a risky endeavor thanks to the fact that these companies face tons of regulatory hurdles, oftentimes the rewards will outweigh the potential downside. A single news headline can send the price of these stocks skyrocketing or plummeting, which is why it’s important to extensively research the companies you are considering before adding them to your portfolio. With that said, biotech stocks are in the spotlight right now thanks to a worldwide focus on public health.

The best biotech companies offer a nice balance between several established drugs bringing the company consistent income along with a robust pipeline of potential blockbuster drugs. However, investing in emerging biotech companies can also pay off in a big way if you can stomach the volatility. Keep reading on to learn about 3 biotech stocks to watch in December. These stocks are worth a look for investors that want to add biotech companies with significant long-term upside. Let’s take a deeper look below.

1. Amgen

The first stock on our list is Amgen (NASDAQ:AMGN), a leading biotech company that produces major treatments for illnesses such as anemia, cancer, osteoporosis, neutropenia, and rheumatoid arthritis. Amgen shareholders have endured a volatile 2020 and the stock is down around 6% year-to-date, which means that investors can add shares of one of the largest biotechnology companies in the world at a very reasonable valuation. The stock also offers a 2.84% dividend yield for some added income and has raised its dividend for 9 consecutive years.

This is a biotech company with a lot of upside going forward, largely due to the company’s Q4 2019 acquisition of Otezla, a leading medication used to treat psoriasis. Amgen has a strong pipeline and there’s also a lot to like about Amgen’s biosimilars business, which could be a big growth driver for the company over the long term. Biosimilars are interesting because they offer a type of biologic therapy that works very similarly to an original biologic treatment but at a lower cost. Companies like Amgen create biosimilars with the idea that they can sell an effective treatment at a lower cost once it is approved by the FDA. Amgen’s biosimilars sales grew 176% year-over-year in Q2 to $478 million, which is certainly a positive development for investors to consider.

2. Sanofi

Next, we have Sanofi (NASDAQ:SNY), a French biotech company that offers a wide range of prescription pharmaceuticals and vaccines. Ever since CEO Paul Hudson (NYSE:HUD) took over in September 2019, the company has been making smart acquisitions and shifting its strategy to focus more on growth drivers. One of the company’s notable drugs, Dupixent, has the potential to become a blockbuster. It’s the first biologic medicine for children aged 6 to 11 years with moderate-to-severe atopic dermatitis. Sales for the drug increased by 68.6% year-over-year in Q3 and the company estimates it could bring in $12 billion in annual sales for the company at some point.

The stock offers investors a strong 3.34% dividend yield and the company generates strong free cash flows thanks to its wide lineup of drugs and vaccines. Sanofi also has two COVID-19 vaccine candidates, which could start the all-important phase 3 trial by the end of the year. The bottom line here is that Sanofi is an intriguing biopharmaceutical stock with a wide economic moat that could end up being a bargain at its current price.

3. Crispr Therapeutics

One of the most attractive qualities of investing in biotech companies is that you are providing capital to businesses that are working to create treatments, medicines, and techniques that can potentially eradicate some of the most serious health issues that humans face. Take Crispr Therapeutics, for example. It’s a company that is focused on using an advanced form of gene editing to cure genetic disorders. The company’s founder, 2020 Nobel Prize Winner in Chemistry Emmanuelle Charpentier, helped to discover the advanced CRISPR technology that allows for precise genetic engineering that can potentially cure genetic disorders afflicting millions of people across the globe.

Crispr Therapeutics has already created a treatment for sickle cell disease and has three anti-cancer compounds that are in early-stage studies. With that said, this is an early-stage company that will likely experience significant volatility over the years. Consider this biotech stock to be a high-risk investment that could become a massive winner. The stock is up over 118% year-to-date and has the potential to finish the year strong after its latest breakout.

Original Post

3 Biotech Stocks To Watch In December

Related Articles

3 Biotech Stocks To Watch In December

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email